Thomas Spitznagel
Vermogen: 142 224 $ op 31-07-2026
Vermogen: 142 224 $ op 31-07-2026
Thomas M.
Spitznagel is Senior Vice President-Technical Operations at MacroGenics, Inc. since 2013.
Formerly, Senior Scientist at Nabi Biopharmaceuticals from 1996 to 1998, Vice President-BioPharmaceutical Development at Human Genome Sciences, Inc. from 1998 to 2012, and Staff Engineer at Genetics Institute LLC in 1996.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MACROGENICS, INC. 0,06% | 15-02-2026 | 38.543 ( 0,06% ) | 142 224 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MACROGENICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 |
| Bedrijven | Functie | Einde |
|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 01-07-2012 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-01-1998 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01-01-1996 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
MacroGenics, Inc.
MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau